| 產(chǎn)品編號(hào) | bs-43195P |
| 英文名稱(chēng) | Recombinant SARS-Cov-2 Spike protein RBD (BA.2.86), (HEK293) |
| 中文名稱(chēng) | 重組SARS冠狀病毒2 Spike突變蛋白R(shí)BD (BA.2.86) |
| 別 名 | SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; Spike protein RBD; SPIKE_SARS2. |
| 理論分子量 | 26.7kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | >1mg/ml |
| 物 種 | SARS-CoV-2 |
| 純 度 | >90% as determined by SDS-PAGE |
| 內(nèi)毒素 | Not analyzed |
| 表達(dá)系統(tǒng) | HEK293 cell |
| 標(biāo)簽 | C-His |
| 緩 沖 液 | PBS (pH=7.4) |
| 保存條件 | >90% as determined by SDS-PAGE |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 | The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. SWISS: P0DTC2 Gene ID: 43740568 Anti-SARS-CoV-2 Spike Protein S（IgM校準(zhǔn)品） 特性：人源單抗(雙鏈抗體)，親和力高，批次質(zhì)量穩(wěn)定 識(shí)別位置：新冠病毒S蛋白R(shí)BD區(qū)域 產(chǎn)品應(yīng)用：ELISA、膠體金層析、化學(xué)發(fā)光等 儲(chǔ)存條件：-20℃保存，避免反復(fù)凍融。 |
| 產(chǎn)品圖片 |  The purity of the protein is greater than 90% as determined by reducing SDS-PAGE. |
我要詢(xún)價(jià)
*聯(lián)系方式：
(可以是QQ、MSN、電子郵箱、電話(huà)等，您的聯(lián)系方式不會(huì)被公開(kāi))
*內(nèi)容：
